Skip to main content
Category

Announcements

INEX Innovate at MEDICA 2022 Dusseldorf to showcase the OvaCis® Rapid Test Kit – the world’s first intraoperative rapid test to effectively discriminate benign from malignant ovarian cysts.

https://www.linkedin.com/posts/inex-innovate_cancer-cancerdiagnostics-earlycancerdetection-activity-6995631127155679233-Qivm/?utm_source=share&utm_medium=member_ios
November 8, 2022
Love0

INEX Innovate is thrilled to share that our Chief Executive, Kane Black, have been selected as Ernst & Young EY Singapore Entrepreneur Of The Year – Biotechnology

https://www.businesstimes.com.sg/companies-markets/six-category-winners-named-for-ey-entrepreneur-of-the-year-2022-awards
October 18, 2022
Love0

https://www.linkedin.com/feed/update/urn:li:activity:6986575451859148800?utm_source=share&utm_medium=member_desktop
October 9, 2022
Love0

INEX Innovate being awarded with SME100 Awards, organized by SME Magazine naming the fastest moving businesses of the SME sector

https://www.linkedin.com/posts/inex-innovate_sme100-inex-igene-activity-6978589114593886208-2RHk?utm_source=share&utm_medium=member_desktop
September 22, 2022
Love0
AS FEATURED ON

Let's shake the diagnostics status quo and put scientific discoveries into clinical practice

Partnerships are vital for continued medical advancements. We constantly seek collaborators to:

  • Support existing research and clinical programmes
  • Diversify our portfolio with new technology in women’s and reproductive health
  • Accelerate the development of innovative diagnostics tools

Let's work together to improve the lives of women around the world.

CONTACT US
Head Office

6 Raffles Quay
#14-04/05
Singapore 048580

Laboratory

1 Science Park Road
#04-10 The Capricorn
Singapore 117528

Connect
Call +65 6773 0698
Fax +65 6873 0240
Terms of Use
Privacy Policy

Please note that the contents of this website are for corporate and non-commercial information purposes only and are provided on the understanding that no surgical or medical advice or recommendation is being rendered. Please refer to our website Terms of Use. The content of this site may not be construed as advertisements for any product or service that INEX or any of its subsidiary companies offers.

© 2023 INEX INNOVATE PRIVATE LIMITED. ALL RIGHTS RESERVED. 0009-0302-00.

About the Technology

A simple sample collection using the common HPV swab is taken and the DNA is extracted. The extracted DNA undergoes bisulfite conversion before an accurate method of screening through real-time PCR analyses. The bisulfite conversion functions by converting unmethylated Cytosine nucleotides to Uracil, which is then converted to Thymine by PCR. Conversely, the methylation mark protects the methylated Cytosine nucleotides from being converted to Uracil.